|4Sep 23, 7:55 PM ET

Burkhart Erin 4

4 · GILEAD SCIENCES, INC. · Filed Sep 23, 2025

Insider Transaction Report

Form 4
Period: 2025-09-22
Burkhart Erin
SVP, Controllership
Transactions
  • Award

    Restricted Stock Unit

    2025-09-22+8,8908,890 total
    Common Stock (8,890 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • [F2]The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Documents

1 file
  • 4
    wk-form4_1758671755.xmlPrimary

    FORM 4